These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19995346)

  • 1. HIV-1 Tat is unconventionally secreted through the plasma membrane.
    Rayne F; Debaisieux S; Bonhoure A; Beaumelle B
    Cell Biol Int; 2010 Mar; 34(4):409-13. PubMed ID: 19995346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells.
    Rayne F; Debaisieux S; Yezid H; Lin YL; Mettling C; Konate K; Chazal N; Arold ST; Pugnière M; Sanchez F; Bonhoure A; Briant L; Loret E; Roy C; Beaumelle B
    EMBO J; 2010 Apr; 29(8):1348-62. PubMed ID: 20224549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1-Tat potentiates CXCL12/stromal cell-derived factor 1-induced downregulation of membrane CXCR4 in T lymphocytes through protein kinase C zeta.
    Hidalgo-Estévez AM; Punzón C; Sanchez-Duffhues G; Muñoz E; Fresno M
    Mol Immunol; 2008 Nov; 46(1):106-15. PubMed ID: 18760839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RCAS1 induced by HIV-Tat is involved in the apoptosis of HIV-1 infected and uninfected CD4+ T cells.
    Minami R; Yamamoto M; Takahama S; Miyamura T; Watanabe H; Suematsu E
    Cell Immunol; 2006 Sep; 243(1):41-7. PubMed ID: 17250817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular HIV-1 tat protein up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells.
    Secchiero P; Zella D; Capitani S; Gallo RC; Zauli G
    J Immunol; 1999 Feb; 162(4):2427-31. PubMed ID: 9973525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression.
    Coiras M; Camafeita E; Ureña T; López JA; Caballero F; Fernández B; López-Huertas MR; Pérez-Olmeda M; Alcamí J
    Proteomics; 2006 Apr; 6 Suppl 1():S63-73. PubMed ID: 16526095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ins and outs of HIV-1 Tat.
    Debaisieux S; Rayne F; Yezid H; Beaumelle B
    Traffic; 2012 Mar; 13(3):355-63. PubMed ID: 21951552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of human immunodeficiency virus type I tat results in down-regulation of bcl-2 and induction of apoptosis in hematopoietic cells.
    Sastry KJ; Marin MC; Nehete PN; McConnell K; el-Naggar AK; McDonnell TJ
    Oncogene; 1996 Aug; 13(3):487-93. PubMed ID: 8760290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand.
    Gibellini D; Re MC; Ponti C; Maldini C; Celeghini C; Cappellini A; La Placa M; Zauli G
    Cell Immunol; 2001 Feb; 207(2):89-99. PubMed ID: 11243698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering, cloning, and functional characterization of recombinant LIM mineralization protein-1 containing an N-terminal HIV-derived membrane transduction domain.
    Sangadala S; Okada M; Liu Y; Viggeswarapu M; Titus L; Boden SD
    Protein Expr Purif; 2009 Jun; 65(2):165-73. PubMed ID: 19284982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of HIV-Tat protein transduction domain.
    Yoon JS; Jung YT; Hong SK; Kim SH; Shin MC; Lee DG; Shin WS; Min WS; Paik SY
    J Microbiol; 2004 Dec; 42(4):328-35. PubMed ID: 15650690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-Tat down-regulates telomerase activity in the nucleus of human CD4+ T cells.
    Franzese O; Comandini A; Adamo R; Sgadari C; Ensoli B; Bonmassar E
    Cell Death Differ; 2004 Jul; 11(7):782-4. PubMed ID: 15017382
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.
    Westendorp MO; Frank R; Ochsenbauer C; Stricker K; Dhein J; Walczak H; Debatin KM; Krammer PH
    Nature; 1995 Jun; 375(6531):497-500. PubMed ID: 7539892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-modulation of cell surface expression of p80 form of the tumor necrosis factor receptor by human immunodeficiency virus-1 tat gene.
    Pocsik E; Higuchi M; Aggarwal BB
    Lymphokine Cytokine Res; 1992 Dec; 11(6):317-25. PubMed ID: 1335762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Tat modulates T-bet expression and induces Th1 type of immune response.
    Kulkarni A; Ravi DS; Singh K; Rampalli S; Parekh V; Mitra D; Chattopadhyay S
    Biochem Biophys Res Commun; 2005 Apr; 329(2):706-12. PubMed ID: 15737643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin T1 stabilizes expression levels of HIV-1 Tat in cells.
    Imai K; Asamitsu K; Victoriano AF; Cueno ME; Fujinaga K; Okamoto T
    FEBS J; 2009 Dec; 276(23):7124-33. PubMed ID: 20064163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophilin A enables specific HIV-1 Tat palmitoylation and accumulation in uninfected cells.
    Chopard C; Tong PBV; Tóth P; Schatz M; Yezid H; Debaisieux S; Mettling C; Gross A; Pugnière M; Tu A; Strub JM; Mesnard JM; Vitale N; Beaumelle B
    Nat Commun; 2018 Jun; 9(1):2251. PubMed ID: 29884859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
    Kashanchi F; Sadaie MR; Brady JN
    Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
    Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
    Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.